dextroamphetamine has been researched along with Palsy in 6 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Excerpt | Relevance | Reference |
---|---|---|
" Behavioral testing, 2 days to 4 mo post-treatment, indicated that DMSO and/or 50 mg/kg of BPAU retarded habituation of spontaneous exploratory activity, impaired acquisition of conditioned (auto-shaped) behavior, and changed the dose-response relationship ford-amphetamine-induced suppression of operant (fixed ratio 32) responding." | 1.27 | Long lasting behavioral effects of dimethyl sulfoxide and the "peripheral" toxicant p-bromophenylacetylurea. ( Fossom, LH; Messing, RB; Sparber, SB, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CARSON, MJ | 1 |
PEARSON, CM | 1 |
Kales, A | 1 |
Cadieux, RJ | 1 |
Soldatos, CR | 1 |
Bixler, EO | 1 |
Schweitzer, PK | 1 |
Prey, WT | 1 |
Vela-Bueno, A | 1 |
Feeney, DM | 1 |
Gonzalez, A | 1 |
Law, WA | 1 |
Gough, AL | 1 |
Olley, JE | 1 |
Fossom, LH | 1 |
Messing, RB | 1 |
Sparber, SB | 1 |
Prabhu, VG | 1 |
Oester, YT | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Treating Comorbid Depression of Patients With Narcolepsy by Intermittent Theta Burst Stimulation: A Preliminary Study[NCT05884112] | 105 participants (Anticipated) | Interventional | 2023-02-22 | Recruiting | |||
Neuroanatomical and Neurophysiological Basis of Motor Recovery Associated With Treatment of Recent Stroke Using Amphetamine and Physical Therapy[NCT00001783] | Phase 2 | 34 participants | Interventional | 1998-04-30 | Completed | ||
Randomized, Placebo-controlled, Double-blind Pilot Trial to Evaluate the Safety and Efficacy of Ropinirole in Motor Recovery After Stroke[NCT00221390] | Phase 2 | 52 participants (Anticipated) | Interventional | 2003-10-31 | Completed | ||
Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment: Double Blinded Comparison Between Botulinum Toxin and Baclofen.[NCT02462317] | Phase 4 | 184 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 other studies available for dextroamphetamine and Palsy
Article | Year |
---|---|
FAMILIAL HYPERKALEMIC PERIODIC PARALYSIS WITH MYOTONIC FEATURES.
Topics: 17-Ketosteroids; Acetazolamide; Adolescent; Biopsy; Blood Chemical Analysis; Child; Dextroamphetamin | 1964 |
Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics.
Topics: Adolescent; Adult; Aged; Catalepsy; Dextroamphetamine; Electroencephalography; Female; Hallucination | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Topics: Animals; Catecholamines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Motor Activity; Mo | 1982 |
delta9-Tetrahydrocannabinol and the extrapyramidal system.
Topics: Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Caudate Nucleus; Dextroamphetamine; Dronabinol; | 1977 |
Long lasting behavioral effects of dimethyl sulfoxide and the "peripheral" toxicant p-bromophenylacetylurea.
Topics: Animals; Behavior, Animal; Body Weight; Conditioning, Operant; Dextroamphetamine; Dimethyl Sulfoxide | 1985 |
Neuromuscular functions of mature mice following neonatal monosodium glutamate.
Topics: Animals; Animals, Newborn; Body Weight; Crowding; Dextroamphetamine; Female; Food Additives; Glutama | 1971 |